Endothelial Dysfunction (Vascular Health-Being)
Fact: >50% of coronary deaths had NO previous symptoms
Fact: 50% men and 64% of women who died suddenly had no symptoms!
Fact: ~50% of heart attacks were NOT “high risk”!
Fact: Patients post heart attack 4-6 times higher risk for a sudden death
(According to the American Heart Association - AHA)
The EndoPAT provides a personalized window to your vascular health.EndoPAT is the leading medical device for non-invasive endothelial function assessment. Endothelial Dysfunction is recognized by the medical community as the critical junction between risk factors and clinical disease. It is the earliest detectable stage of cardiovascular disease. The EndoPAT ™ adds an important dimension to cardiovascular prevention by enabling physicians to reliably measure endothelial function and identify pathological cases of endothelial dysfunction at early stages.
EndoPAT ™ Major Features and Advantages:
• FDA cleared and CE marked
• Reliable and reproducible results
It is used in preeminent clinical and research institutions, major epidemiological population-based studies (such as Framingham Heart Study), and pharmaceutical clinical phase studies in over 40 countries, with thousands of tests are performed worldwide every month.